DPP4 and type 2 diabetes mellitus: In humans, DPP4 inhibition was associated with reduced albuminuria in the Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes (SAVOR-TIMI 53) trial26.